Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01430689Phase 4Completed
Phase 4, randomised, single-blind trial of influenza vaccine in influenza (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Number of infants with influenza whose mothers received vaccine at any time during the 3rd trimester at 2 years. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01430689.